VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 117 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,724 | -23.0% | 39,751 | +17.5% | 0.00% | – |
| Q2 2023 | $222,933 | -20.5% | 33,829 | -18.1% | 0.00% | – |
| Q1 2023 | $280,311 | -17.0% | 41,283 | -9.7% | 0.00% | – |
| Q4 2022 | $337,856 | -12.9% | 45,718 | +16.3% | 0.00% | – |
| Q3 2022 | $388,000 | -24.7% | 39,302 | -16.7% | 0.00% | – |
| Q2 2022 | $515,000 | -16.1% | 47,153 | -13.1% | 0.00% | – |
| Q1 2022 | $614,000 | -32.8% | 54,270 | -6.8% | 0.00% | – |
| Q4 2021 | $914,000 | -12.9% | 58,213 | -4.8% | 0.00% | – |
| Q3 2021 | $1,049,000 | -67.4% | 61,154 | -59.1% | 0.00% | -100.0% |
| Q2 2021 | $3,215,000 | +37.9% | 149,490 | -3.7% | 0.00% | +100.0% |
| Q1 2021 | $2,332,000 | +168.0% | 155,275 | +134.5% | 0.00% | 0.0% |
| Q4 2020 | $870,000 | +79.0% | 66,216 | +31.5% | 0.00% | – |
| Q3 2020 | $486,000 | -54.3% | 50,370 | -45.8% | 0.00% | -100.0% |
| Q2 2020 | $1,063,000 | -77.8% | 93,008 | -79.9% | 0.00% | -75.0% |
| Q1 2020 | $4,789,000 | +1387.3% | 462,345 | +2248.7% | 0.00% | – |
| Q4 2019 | $322,000 | -69.0% | 19,685 | -74.9% | 0.00% | -100.0% |
| Q3 2019 | $1,038,000 | -89.8% | 78,294 | -89.2% | 0.00% | -83.3% |
| Q2 2019 | $10,197,000 | +330.8% | 723,786 | +462.2% | 0.01% | +500.0% |
| Q1 2019 | $2,367,000 | -34.9% | 128,731 | -7.6% | 0.00% | -66.7% |
| Q4 2018 | $3,638,000 | -70.7% | 139,273 | -74.3% | 0.00% | -25.0% |
| Q3 2018 | $12,433,000 | +167.0% | 541,781 | +121.6% | 0.00% | +300.0% |
| Q2 2018 | $4,657,000 | +356.1% | 244,472 | +302.9% | 0.00% | – |
| Q1 2018 | $1,021,000 | -40.4% | 60,678 | -46.2% | 0.00% | -100.0% |
| Q4 2017 | $1,712,000 | -53.0% | 112,712 | -44.7% | 0.00% | -50.0% |
| Q3 2017 | $3,646,000 | -22.9% | 203,817 | -29.8% | 0.00% | -33.3% |
| Q2 2017 | $4,729,000 | +11.7% | 290,230 | -4.1% | 0.00% | 0.0% |
| Q1 2017 | $4,233,000 | +0.6% | 302,489 | +14.7% | 0.00% | 0.0% |
| Q4 2016 | $4,206,000 | +11.2% | 263,800 | +16.0% | 0.00% | 0.0% |
| Q3 2016 | $3,784,000 | +3.6% | 227,479 | -30.4% | 0.00% | 0.0% |
| Q2 2016 | $3,654,000 | +5.9% | 326,765 | -20.8% | 0.00% | 0.0% |
| Q1 2016 | $3,450,000 | -14.1% | 412,819 | -4.3% | 0.00% | 0.0% |
| Q4 2015 | $4,014,000 | -5.3% | 431,230 | +14.7% | 0.00% | 0.0% |
| Q3 2015 | $4,238,000 | +36.8% | 375,868 | +53.9% | 0.00% | +50.0% |
| Q2 2015 | $3,098,000 | -14.7% | 244,229 | -37.5% | 0.00% | 0.0% |
| Q1 2015 | $3,631,000 | -1.5% | 390,805 | +51.8% | 0.00% | 0.0% |
| Q4 2014 | $3,685,000 | +91.5% | 257,498 | +38.8% | 0.00% | +100.0% |
| Q3 2014 | $1,924,000 | -10.5% | 185,562 | +39.5% | 0.00% | 0.0% |
| Q2 2014 | $2,149,000 | -63.7% | 132,985 | -64.5% | 0.00% | -75.0% |
| Q1 2014 | $5,920,000 | +777.0% | 374,353 | +513.7% | 0.00% | – |
| Q4 2013 | $675,000 | -90.7% | 60,995 | -90.8% | 0.00% | -100.0% |
| Q3 2013 | $7,270,000 | – | 664,889 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |